Tackling Retirements, Staffing Gaps, and Documentation Risks SAN RAMON, CA / ACCESS Newswire / September 11, 2025 / ARC Facilities today announced an upcoming webinar designed to help facility management leaders address some of the most pressing challenges facing the industry: the loss of institutional knowledge due to retirements, widespread staffing shortages, and incomplete asset […]

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities prior to January 3, 2024, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agios Pharmaceuticals, Inc. ("Agios" or "the Company") (NASDAQ:AGIO). Investors who purchased Agios securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AGIO.

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE ("Valneva" or "the Company") (NASDAQ:VALN). Investors who purchased Valneva securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG). Investors who purchased PepGen securities prior to March 7, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX). Investors who purchased Pacira securities prior to August 2, 2023, and continue to hold to the present, are encouraged to obtain additional

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Civitas Resources, Inc. ("Civitas" or "the Company") (NYSE:CIVI). Investors who purchased Civitas securities prior to February 27, 2024, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged to